The DOI matches its Crossref record; 12 of the 13 references it cites were found in a registry or an index.
Rationale for WHO's New Position Calling for Prompt Reporting and Public Disclosure of Interventional Clinical Trial Results
Open accessAbstract
On April 14, 2015, the World Health Organization (WHO) published a new statement on the public disclosure of clinical trial results (S1 Text) [1].The WHO statement not only re-affirms the ethical imperative of clinical trial results reporting, it also defines reporting timeframes, calls for results-reporting of older but still unpublished trials, and outlines steps to improve linkages between clinical trial registry entries and their published results.This updates and expands WHO's 2005 statement that "the registration of all interventional trials is a scientific, ethical, and moral responsibility" [2].WHO's 2005 statement called for all interventional clinical trials to be registered.Subsequently, there has been an increase in clinical trial registration prior to the start of trials.This has enabled tracking of the completion and timeliness of clinical trial reporting.There is now a strong body of evidence showing failure to comply with results-reporting requirements across intervention classes, even in the case of large, randomised trials [3][4][5][6][7].This applies to both industry and investigator-driven trials.In a study that analysed reporting from large clinical trials (over 500 participants) registered on clinicaltrials.govand completed by 2009, 23% had no results reported even after a median of 60 months following trial completion; unpublished trials included nearly 300,000 participants [3].Among randomised clinical trials (RCTs) of vaccines against five diseases registered in a variety of databases between 2006-2012, only 29% had been published in a peer-reviewed journal by 24 months following study completion [4].At 48 months after completion, 18% of trials were not reported at all, which included over 24,000 participants.In another study, among 400 randomly selected clinical trials, nearly 30% did not publish the primary outcomes in a journal or post results to a clinical trial registry within four years of completion [5].The Declaration of Helsinki and other statements have outlined the compelling reasons why interventional clinical trials should be reported in a timely fashion [8][9][10].In brief, not reporting clinical trial results is likely to lead to dissemination bias.This bias has the following major adverse consequences:• It affects understanding of the scientific state of the art.• It leads to inefficiencies in resource allocation for both research and development and financing of health interventions.• It creates indirect costs for public and private entities, including patients themselves, who pay for suboptimal or harmful treatments.• It potentially distorts regulatory and public health decision making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Delays in CPR initiation due to donning of personal protective equipment may impact patient outcomes, 385,386,388 and thereby modify the measured effect of concurrent or subsequent, investigational, resuscitative interventions, such as new drug therapies, or temperature/ventilatory management during and/or after resuscitation.”
From European Resuscitation Council Guidelines 2021: Ethics of resuscitation and end of life decisions (2021) · cites this paper as [388]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,825
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Zhou, Q.-H. (2015) · Chinese Nursing Research · doi:10.1016/j.cnre.2016.01.001 · Cited by 738
Underreporting Research Is Scientific Misconduct
Chalmers, I. (1990) · JAMA · doi:10.1001/jama.263.10.1405 · Cited by 640
International Committee of Medical Journal Editors.
Riis, P. J. (1990) · PubMed · Cited by 415
Non-publication of large randomized clinical trials: cross sectional analysis
Jones, C. W., Handler, L., Crowell, K. E., Keil, L. G., Weaver, M. A., & Platts-Mills, T. F. (2013) · BMJ · doi:10.1136/bmj.f6104 · Cited by 350
Schmucker, C., Schell, L. K., Portalupi, S., Oeller, P., Cabrera, L., Bassler, D., Schwarzer, G., Scherer, R. W., Antes, G., von Elm, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114023 · Cited by 269
Sharing and Reporting the Results of Clinical Trials
Hudson, K., & Collins, F. S. (2014) · JAMA · doi:10.1001/jama.2014.10716 · Cited by 130
The International Committee of Medical Journal Editors
van der Weyden, M. V. (2006) · doi:10.2349/biij.2.4.e54-13 · Cited by 110
Cited by
Sorted by citations
Items 101–154 of 154
Research integrity and the law that never was
Mayer, M. G. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2018-110993 · Cited by 2
Bradley, S. H., DeVito, N., Lloyd, K. E., Richards, G. C., Rombey, T., Wayant, C., & Gill, P. J. (2020) · doi:10.31222/osf.io/jy37f · Cited by 2
Al-Durra, M., Nolan, R. P., Seto, E., & Cafazzo, J. A. (2022) · Digital Health · doi:10.1177/20552076221090034 · Cited by 2
Morley, G. (2015) · Medical Writing · doi:10.1179/2047480615z.000000000300 · Cited by 1
Harugeri, A., Shastri, V., & Patel, C. (2017) · Perspectives in Clinical Research · doi:10.4103/2229-3485.203046 · Cited by 1
Potenziale und Trends der Digitalisierung in der Pharmaindustrie im Kontext von E-Health
Schweizer, L., & Hüning, C. (2020) · Springer eBooks · doi:10.1007/978-3-658-26670-7_3 · Cited by 1
Psychopharmacology for Children and Adolescents: A Paradigm Shift
Harper, G. P., Parry, P. I., Ng, J. W. L., & Seshadri, S. P. (2016) · Springer eBooks · doi:10.1007/978-81-322-3619-1_16
Results of all clinical trials should be posted within a year, says WHO
Wise, J. (2015) · BMJ · doi:10.1136/bmj.h1987
Should a Trial with Lost Allocation Key be Incorporated in Meta-analysis?
Pijls, B. G. C. W., van der Burg, B. L. S. B., Frisch, L., Vochteloo, A. J. H., & Nelissen, R. G. H. H. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/17815
Appraisal of a redundant report on lanthanum carbonate
Habbous, S., Garg, A. X., & Martin, J. E. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1159-x
WHO calls for full disclosure of clinical trials
Woolston, C. (2015) · Nature · doi:10.1038/520411f
Snape, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12306-6
Technology assessment: A role for UNESCO and S&T parks
Oh, D.-S., & Phillips, F. Y. (2016) · Portland International Conference on Management of Engineering and Technology (PICMET) · doi:10.1109/picmet.2016.7806605
Evidence-based Medicine in Cardiac Imaging
Zaman, M. U., & Fatima, N. (2019) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2019.07.597
Pluralist Accountability in Global Health Governance
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0007
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0001
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0008
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0002
“We cannot rule out that torture is going on”
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0003
Bringing Peace, But Violating Human Rights
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0005
Pluralist Accountability in Times of Economic Crisis
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.003.0006
Is there reporting and citation bias for completed phase III interventional brain tumor trials?Preprint
Rayi, A., Alnahhas, I., Giglio, P., & Puduvalli, V. K. (2020) · medRxiv · doi:10.1101/2020.08.10.20172296
Grabitz, P., Brückner, T., & Strech, D. (2020) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-020-03246-0
Blümle, A., Wollmann, K., Bischoff, K., Lohner, S., Nury, E., Nitschke, K., Rücker, G., & Schumacher, M. C. (2020) · doi:10.21203/rs.3.rs-106925/v1
国際臨床試験(研究)登録プラットフォームにおける登録項目 WHO-ICTRPの動向
麻理子, 土., 慶子, 湯., & 元, 佐. (2020) · Institutional Repositories DataBase (IRDB) · doi:10.20683/jniph.69.3_234
Current Status and Issues of Ethical Review for Surgical Research in Japanese University Hospitals
Doi, M., Yukawa, K., & Satō, H. (2022) · JMA Journal · doi:10.31662/jmaj.2020-0117
(2020) · The MIT Press eBooks · doi:10.7551/mitpress/11885.003.0037
Negoro, T., Okura, H., Hayashi, S., Arai, T., & Matsuyama, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1425336/v1
Integrating Research and Evidence‐Based Practice
O’Donnell, A., Boyd, R. E., & McVeigh, C. (2023) · doi:10.1002/9781119867029.ch7
Obstacles with Ethics in Resuscitation with Several Comorbidities
(2023) · Journal of Clinical Review & Case Reports · doi:10.33140/jcrc.08.10.03
Brückner, T., Chen, Y., Cruz, C., Dike, C. E., Chavarría, B., Chen, S., Dzidzornu, E. D., & Ringsten, M. (2024) · medRxiv · doi:10.1101/2024.03.17.24304386
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.002.0004
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.002.0003
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.002.0006
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.002.0007
Hirschmann, G. (2020) · doi:10.1093/oso/9780198861249.002.0008
Appendix 2: Initiatives to Improve the Quality of Research
Crombie, I. (2021) · Wiley eBooks · doi:10.1002/9781394322183.app2
Congenital Heart Disease as a Cause of Maternal Death: Literature Review
Mahendra, A. A., Andrianto, A., & Cahya, M. A. (2025) · International Journal Of Scientific Advances · doi:10.51542/ijscia.v6i1.3
Khan, A., Smith, T., Chaudhry, A., Smith, C., Nees, D., Hughes, G. K., Rowsey, K., & Vassar, M. B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322003
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551199
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551175
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551172
Additional file 1 of Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
Rojek, A. M., Martin, G. E., & Horby, P. W. (2020) · Figshare · doi:10.6084/m9.figshare.12845555
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551193
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551196
Jones, C. W., Adams, A., Murphy, E., King, R., Saracco, B., Stesis, K., Cavanaugh, S., Roberts, B. W., & Platts-Mills, T. F. (2021) · Figshare · doi:10.6084/m9.figshare.14752319
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551184
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551181
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551190
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551187
Blümle, A., Wollmann, K., Bischoff, K., Kapp, P., Lohner, S., Nury, E., Nitschke, K., Zähringer, J., Rücker, G., & Schumacher, M. (2021) · Figshare · doi:10.6084/m9.figshare.16551178
The Importance of Clinical Trial Registries as a Mitigation to Bias in Evidence-Based Research
Al-Durra, M. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014485
Metadata
- Authors
- Moorthy, V. S., Karam, G., Vannice, K. S., & Kieny, M.-P.
- Affiliations
- World Health Organization (CH)
- Corresponding author
- Moorthy, Vasee S.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-14
- Volume
- 12
- Issue
- 4
- Pages
- e1001819
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC4396122
- OpenAlex
- W1996092618
- Cited by
- 155
- References
- 13
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 11 · 2022: 9 · 2021: 19 · 2020: 27 · 2019: 8 · 2018: 13 · 2017: 14 · 2016: 27 · 2015: 16
- FWCI
- 27.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- World Health Organization
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- public disclosure, clinical trial registration, reporting timeliness, unpublished trials, dissemination bias, clinical trial registries, randomized controlled trials, vaccine clinical trials, research integrity
- MeSH terms
- Clinical Trials as Topic, Humans, Morals, Publishing, Registries, Science, World Health Organization, Bias, Disclosure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review